Ian L McAllister

7PUBLICATIONS
20CO-AUTHORS
HaematologyGene expression (incl. microarray and other genome-wide approaches)Optical technologyGenetic immunologyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.

Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold

|Dec 24, 2021
Genotype-Specific Lesion Growth Rates in Stargardt Disease.

Rachael C Heath Jeffery, Jennifer A Thompson, Johnny Lo

|Aug 03, 2021
Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.

Elisa E Cornish, Kelvin Yc Teo, Mark C Gillies

|May 03, 2021
Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia.

Rachael C Heath Jeffery, Syed Aqif Mukhtar, Ian L McAllister

|Mar 26, 2021
Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy.

Ian L McAllister, Lynne A Smithies, Fred K Chen

|Mar 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.

Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher

Pageof 2

Frequent Collaborators

3 joint publications

Vuong Nguyen

2 joint publications

Adrian Robert Hunt

2 joint publications

Pierre-Henry Gabrielle

2 joint publications

Samantha Fraser-Bell